Clinical Trial Update: A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC) [Phase 2]

View source ↗

Summary

Phase 2 trial update for TD-1211 in opioid-induced constipation completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• TD-1211

Snippet

Sponsor: Theravance Biopharma | Conditions: Opioid Induced Constipation | Phase 2 | Status: COMPLETED